Guidelines for diagnosis and treatment of carcinoma of the Esophagus April 2012 edited by the Japan esophageal society

Esophagus

Volumn 12, Issue 1, 2015, Pages 1-30

  Kuwano, Hiroyuki ^a   Nishimura, Yasumasa ^b   Oyama, Tsuneo ^c   Kato, Hiroyuki ^d   Kitagawa, Yuko ^e   Kusano, Motoyasu ^f   Shimada, Hideo ^g   Takiuchi, Hiroya ^h   Toh, Yasushi ⁱ   Doki, Yuichiro ^j   Naomoto, Yoshio ^k   Matsubara, Hisahiro ^l   Miyazaki, Tatsuya ^a   Muto, Manabu ^m   Yanagisawa, Akio ⁿ  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f GUNMA UNIVERSITY HOSPITAL   (Japan)

^g TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^h OSAKA MEDICAL COLLEGE   (Japan)

ⁱ NATIONAL KYUSHU CANCER CENTER   (Japan)

^j OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k KAWASAKI MEDICAL SCHOOL   (Japan)

^l CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m KYOTO UNIVERSITY   (Japan)

ⁿ KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

more..

Author keywords

Clinical guidelines; Esophagus; Neoplasm

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IRINOTECAN; MITOMYCIN; NAVELBINE; NEDAPLATIN; PACLITAXEL; VINDESINE;

ADJUVANT CHEMOTHERAPY; ADVERSE OUTCOME; ARTICLE; BARRETT CARCINOMA; BARRETT ESOPHAGUS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CHEMORADIOTHERAPY; CLINICAL TRIAL (TOPIC); DRUG CHOICE; DRUG EFFICACY; ENDOSCOPIC SURGERY; ESOPHAGUS ANASTOMOSIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; EUROPE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEART FUNCTION TEST; HUMAN; INFORMED CONSENT; INTRACAVITARY RADIATION; JAPAN; KIDNEY FUNCTION TEST; LARYNGECTOMY; LARYNGOPHARYNGOESOPHAGECTOMY; LARYNX CONSERVING SURGERY; LIVER FUNCTION TEST; LOWER ESOPHAGUS SPHINCTER; LOWER THORACIC ESOPHAGEAL CARCINOMA; LUNG FUNCTION TEST; LYMPH NODE DISSECTION; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MIDDLE THORACIC ESOPHAGEAL CARCINOMA; MONOTHERAPY; MORBIDITY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NORTH AMERICA; PERFORMANCE; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SALVAGE THERAPY; STOMACH CARCINOMA; TRANSHIATAL ESOPHAGECTOMY; TREATMENT INDICATION;

EID: 84929336574     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-014-0465-1     Document Type: Article

References (0)